Park City, UTNCT05516472Now EnrollingIRB Ready

Kidney Stones Clinical Trial in Park City, UT

Access cutting-edge kidney stones treatment through this clinical trial at a research site in Park City. Study-provided care at no cost to qualified participants.

Sponsored by Joshua Stern

Quick Self-Assessment

See if you qualify for this Park City location

Preparing your pre-screening questions…

Expert Care in Park City

Access kidney stones specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related kidney stones treatment provided free

Apply for This Park City Location

Check if you qualify for this kidney stones clinical trial in Park City, UT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Park City

    Convenient for UT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Park City site if eligible
  4. 4Begin participation

About This Kidney Stones Study in Park City

The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on 24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.

Sponsor: Joshua Stern

Who Can Participate

Inclusion Criteria

Women and men age greater than or equal to 18 and less than 70
Recent medical history of USD with greater than or equal to 50% calcium-oxalate stones. All patients will have urinary stone disease confirmed by stone analysis. The study will include patients with either stones extracted by urological intervention or spontaneously passed and collected stones.
24-hour urinary calcium concentration greater than 225 mg/day or urinary oxalate greater than 40 mg/day
Able to give informed consent.
Willing to undergo telephone follow-up to assess for safety and adverse events
Willing and able to participate in the study requirements, including study visits, 24-hour urine collection and serial stool collection
Not actively participating in another interventional USD clinical trial
Estimated Glomerular Filtration Rate (eGFR) greater than or equal to 60.

Exclusion Criteria

Presence of three features of metabolic syndrome as defined by the NIH to have 3 or more of the following conditions:
Large waist - A waistline that measures at least 35 inches (89 centimeters) for women and 40 inches (102 centimeters) for men
High triglyceride level - 150 milligrams per deciliter (mg/dL), or 1.7 millimoles per liter (mmol/L), or higher of this type of fat found in blood
Reduced good or HDL cholesterol - Less than 40 mg/dL (1.04 mmol/L) in men or less than 50 mg/dL (1.3 mmol/L) in women of high-density lipoprotein (HDL) cholesterol
Increased blood pressure - 130/85 millimeters of mercury (mm Hg) or higher
Elevated fasting blood sugar - 100 mg/dL (5.6 mmol/L) or higher
Presence of features of autoimmunity
Major gastrointestinal surgery (e.g. significant bowel resection) within 3 months before enrollment. This does not include appendectomy or cholecystectomy
Diagnosis of inflammatory bowel disease
Patient diagnosed with primary hyperparathyroidism. Any patient with a PTH outside the range of 15 - 65 pg/ml will be excluded.
Patient diagnosed secondary hyperparathyroidism. Any patient with a PTH outside the range of 15 - 65 pg/ml will be excluded.
All patients requiring pancreatic enzyme replacement will be excluded.
Patient with ongoing dialysis treatment
Received chemotherapy treatment in the last 1 year
Treatment with antibiotics within 3 months of study entry. If subjects need to take antibiotics unexpectedly during the trial, they are excluded if they have already taken the fecal material transplant; if not, they can re-enroll in 3 months.
Patients taking potassium citrate, thiazides, or proton pump inhibitors in the last 6 months
Women who are pregnant or breast-feeding or planning to get pregnant during the time of the study.
Inability (e.g. dysphagia) to or unwilling to swallow capsules. Subjects with Grade greater than or equal to 2 dysphagia- as per Current Terminology for Common Adverse Events (CTCAE v 5.0) will be excluded.
Active gastrointestinal infection at time of enrollment
Requires continued antibiotic use or anticipates antibiotic use in the upcoming 4 weeks
Known or suspected toxic megacolon and/or known small bowel ileus
History of total colectomy or bariatric surgery
Concurrent intensive induction chemotherapy, radiation therapy or biological treatment for active malignancy
Expected life expectancy less than 6 months
Previous FMT or microbiome-based products at any time excluding this study
Patients with a history of severe anaphylactic or anaphylactoid food allergy
Solid organ transplant recipients (all patients with a history of solid organ transplant will be excluded).
A condition that would jeopardize the safety or rights of the subject, would make it unlikely for the subject to complete the study, or would confound the results of the study.
Subjects will be excluded if they have chronic kidney disease defined as GFR (Glomerular Filtration Rate) less than 60.
Subjects with urinary oxalate greater than or equal to 80 mg/d will be excluded

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Park City?

Yes, this clinical trial (NCT05516472) has an active research site in Park City, UT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Kidney Stones Treatment Options in Park City, UT

If you're searching for kidney stones treatment options in Park City, UT, this clinical trial (NCT05516472) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Park City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced kidney stones specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all kidney stones clinical trials near you to find additional studies recruiting in your area.

More Kidney Stones Trials in Park City, UT

See all kidney stones clinical trials recruiting in Park City — not just this study.

Browse Kidney Stones Trials in Park City →

Browse More Trials by Condition

Kidney Stones TrialsAll Conditions →

Ready to Join in Park City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Park City, UT